Physician profile
Katie E Ormond
NPI 1023573037
$450.67
in general payments reported to CMS, 2019-2025
17 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.72 · 2022: $4.68 · 2023: $96.48 · 2024: $193 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $58.01 | 2023-2024 | Otezla, Repatha, Aimovig |
| Glaxosmithkline, LLC. | $54.08 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.37 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $46.91 | 2023-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $35.40 | 2024-2025 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $28.90 | 2024-2025 | Airsupra |
| Sanofi Pasteur INC. | $24.37 | 2025 | |
| Medtronic, INC. | $24.33 | 2023 | Valiant Captivia |
| Sanofi-Aventis U.S. LLC | $20.72 | 2021 | |
| Tolmar, INC. | $19.78 | 2025 | Jatenzo |
| Dexcom, INC. | $17.48 | 2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.83 | 2025 | Xifaxan |
| Azurity Pharmaceuticals, INC. | $14.48 | 2024 | Horizant |
| Daiichi Sankyo INC. | $13.66 | 2023 | Injectafer |
| Pfizer INC. | $13.61 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $8.06 | 2025 | Voquezna |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Ormond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.